Mike Dreyer Patient Spouse

Mike’s wife Jeanie was diagnosed with Multiple Myeloma in June, 2010.  In an effort to motivate Jeanie through recovery of her first stem cell transplant in 2010, Mike signed up for his first sprint triathlon with her in 2011 and has been pursuing greater challenges every year.  He has cheered her on through 3 marathons post-transplant, including Boston and NYC for the MMRF,  and has joined her for a marathon and a couple of Spartan events, a Spartan Beast in 2014 and Spartan Fenway as part of the MMRF Endurance Team in 2015.  As a frequent member of MMRF Endurance Team events, Mike has participated in several MMRF events including the inaugural R2V as a member of the Desert Team ( CA to AZ ) and his first ironman at Mont-Tremblant. He has personally seen the positive impact that these events have made on the patients and the MM community, along with the incredible results and quality of life that the MMRF has delivered because of the fundraising.

My 3 Wishes for Multiple Myeloma Patients
Mike Dreyer
MM could take away time, but it wasn’t going to take away meaning. For her, hours, minutes, and days had more purpose and meaning and she has learned and taught…
Read More
09/10/2019
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More